Skip to main content
PMC home page
Oncotarget logoLink to Oncotarget
. 2018 Oct 16;9(81):35284. doi: 10.18632/oncotarget.26254

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer

Naiqing Xu 1,2,3,*, Wenfeng Fang 4,*, Libing Mu 5, Yanna Tang 4, Lei Gao 2, Shengxiang Ren 6, Dengfeng Cao 7, Lixin Zhou 8, Aiqun Zhang 9, Deruo Liu 10, Caicun Zhou 6, Kwok-Kin Wong 11, Lei Yu 12, Li Zhang 4, Liang Chen 1,2,3,13
PMCID: PMC6219656  PMID: 30443296

This article has been corrected: The correct Grant Support information is given below:

GRANT SUPPORT

This work was funded by National Natural Science Foundation of China grant 81472606, Chinese Ministry of Science and Technology grant (973 grant) 2011CB812401, and the Beijing Municipal Government.

Original article: Oncotarget. 2016; 7:3884-3896. https://doi.org/10.18632/oncotarget.6461

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES